ロード中...
Alectinib in the treatment of ALK-positive metastatic non-small cell lung cancer: clinical trial evidence and experience with a focus on brain metastases
Molecular profiling of metastatic nonsquamous non-small cell lung cancer (NSCLC) is required to guide the treatment strategy. Anaplastic lymphoma kinase (ALK) gene rearrangements are found in approximately 5% of lung adenocarcinomas and are associated with specific clinical features including a high...
保存先:
| 出版年: | Ther Adv Respir Dis |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SAGE Publications
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6385324/ https://ncbi.nlm.nih.gov/pubmed/30786826 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1753466619831906 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|